Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04382898
Title PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) (PRO-MERIT)
Acronym PRO-MERIT
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | HUN | GBR | DEU


No variant requirements are available.